Comparative activities of amoxycillin and 10 other oral drugs against penicillin-susceptible and -resistant Streptococcus pneumoniae strains recently isolated in Italy

Clinical Microbiology and Infection

Volumn 4, Issue 3, 1998, Pages 170-173

  Marchese, Anna ^a   Debbia, Eugenio ^a   Pesce, Adelaide ^a   Schito, Gian Carlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENCY; ITALY; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0031889773     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00385.x     Document Type: Article

References (17)

1. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-82.
2. Finch RG. The role of new quinolones in the treatment of respiratory tract infections. Drugs 1995; 49(suppl 2): 144-51.
3. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80.
4. Carratalà J, Marron A, Fernandez-Sevilla A, Liñares J, Gudiol F. Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer. Clin Infect Dis 1996; 24: 148-52.
5. Goldstein FW, Acar JF, the Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of 1992-93 Western Europe and USA Collaborative surveillance study. J Antimicrob Chemother 1996; 38 (suppl A): 71-84.
6. Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxicillin, amoxicillin/clavulanate and cefotaxime against 189 penicillin-susceptible and - resistant pneumococci. J Antimicrob Chemother 1995; 35: 883-8.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. Approved Standard M7-A3. Villanova, PA: NCCLS, 1995.
8. Severin A, Severina E, Tomasz A. Abnormal physiological properties and altered cell wall composition in S. pneumoniae grown in the presence of clavulanic acid. Antimicrob Agents Chemother 1997; 41: 504-10.
9. Visalli MA, Jacobs MR, Appelbaum PC. MIC and time-kill study of activities of DU-6859a, ciprofloxacin. levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996; 40: 362-6.
10. Simor AE, Louie M, the Canadian Bacterial Surveillance Network, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2190-3.
11. Barry AL, Fuchs PC, Brown SD. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob Agents Chemother 1996, 40: 2431-3.
12. Coque TM, Singh KV, Murray BE. Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci. J Antimicrob Chemother 1996; 37: 1011-16.
13. Johnson AP, Speller DCE, Warner M, Domingue G. Invitro activity of levofloxacin (1-ofloxacin), ofloxacin and ciprofloxacin against clinical isolates of Streptococcus pneumoniae obtained in England and Wales. J Antimicrob Chemother 1996; 38: 907-8.
14. Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and other antibiotics. J Antimicrob Chemother 1995; 36: 833-7.
15. Örtqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 1995; 35: 205-12.
16. Schito GC, Pesce A, Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis? J Antimicrob Chemother 1997; 39: 562-5.
17. Book I. Microbiology and management of sinusitis. J Otolaryngol 1997; 25: 249-56.